Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-2901

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-2901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2901 3)

Pdp (68071 2901 3)
Ondansetron ODT 4 mg orally disintegrating tablets, package of 30, from NuCare Pharmaceuticals, Inc. The label includes the NDC number 68071-2901-3 and specifies prescription-only use. It features dosing and storage information, manufacturer details, and warnings to keep out of reach of children and store at controlled temperatures between 68-77°F.*
FDA Label Image
FDA Label Image

Structure-base (Structure Base)

Structure-base (Structure Base)
Chemical structure diagram of ondansetron, showing its molecular framework with various rings and functional groups.*
FDA Label Image

Structure-hcl (Structure HCl)

Structure-hcl (Structure HCl)
Chemical structure diagram of Ondansetron hydrochloride dihydrate, showing the molecular arrangement of the compound with multiple rings including a methylated indole and imidazole system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.